Allscripts Healthcare Solutions, Inc. (Allscripts) MDRX today announced its financial results for the three months ended December 31, 2010.
Fourth Quarter Highlights:
Fourth quarter total bookings of $288.2 million, including legacy Allscripts bookings of $140.4 million and legacy Eclipsys bookings of $147.8 million
Total bookings growth of 34 percent sequentially over the third quarter of 2010
Legacy Eclipsys bookings growth of 31 percent in calendar 2010
GAAP revenue of $316.2 million; total non-GAAP revenue of $337.1 million, a 10 percent year-over-year increase
GAAP operating income of $9.5 million; total non-GAAP operating income of $69.3 million, a 26 percent year-over-year increase
GAAP net loss of $6.2 million and diluted net loss per share of $0.03; total non-GAAP net income of $38.7 million and non-GAAP diluted earnings per share of $0.20
Non-GAAP net income and earnings per share reflect adjustments to GAAP results, largely associated with the Eclipsys merger, all on a net-of-tax basis, consisting of:
$12.7 million or $0.07 per share for an acquisition-related deferred revenue adjustment;
$10.6 million or $0.05 per share for acquisition-related amortization expense;
$2.3 million or $0.01 per share for stock-based compensation expense; and,
$10.9 million, or $0.06 per share for transaction-related expenses;
$8.4 million, or $0.04 per share of additional income tax expense primarily related to non-deductible merger-related expenses
$74.3 million in cash flow from operations; reduced long-term debt by $40.9 million
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in